Molecular characterization of antitumor effects of the rhizome extract from Curcuma zedoaria on human esophageal carcinoma cells

Hadisaputri,Yuni  Elsa; Miyazaki,Tatsuya; Suzuki,Shigemasa; Kubo,Norio; Zuhrotun,Ade; Yokobori,Takehiko; Abdulah,Rizky; Yazawa,Shin; Kuwano,Hiroyuki

doi:10.3892/ijo.2015.3199

Molecular characterization of antitumor effects of the rhizome extract from Curcuma zedoaria on human esophageal carcinoma cells

Authors:
- Yuni Elsa Hadisaputri
- Tatsuya Miyazaki
- Shigemasa Suzuki
- Norio Kubo
- Ade Zuhrotun
- Takehiko Yokobori
- Rizky Abdulah
- Shin Yazawa
- Hiroyuki Kuwano
View Affiliations

Affiliations: Department of General Surgical Science, Gunma University, Graduate School of Medicine, Maebashi 371-8511, Gunma, Japan, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Bandung, Indonesia, Department of Molecular and Cellular Pharmacology, Gunma University, Graduate School of Medicine, Maebashi 371-8511, Gunma, Japan
Published online on: October 13, 2015 https://doi.org/10.3892/ijo.2015.3199
Pages: 2255-2263

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcuma zedoaria has been used as a traditional agent against malignant diseases. To elucidate detailed mechanisms producing such an activity, characterization and determination of molecular mechanisms of its antitumor effects was conducted. Inhibiting activities against cell proliferation, invasion and colony formation, and expression levels of corresponding molecules were investigated using human esophageal cancer TE-8 cells treated with the rhizome extract from C. zedoaria. Antitumor effect of the extract administered orally was also examined in tumor-bearing mice. The extract possessed strong anti-proliferation and invasion activities against TE-8 cells. Further, upregulated PTEN and downregulated phosphorylated Akt, mTOR and STAT3 expressions in the cells were induced shortly after treatment with the extract, followed by attenuation of FGFR1 and MMP-2, activation of caspase-9, caspase-3 and PARP, and suppression of Bcl-2 expressions, which led the cells to apoptotic cell death. Furthermore, tumor formation in mice was significantly suppressed through the oral administration of the extract. Taken together, these results suggest that the C. zedoaria extract could be a promising agent against esophageal cancer.

View Figures

View References

1	Mishra BB and Tiwari VK: Natural products: An evolving role in future drug discovery. Eur J Med Chem. 46:4769–4807. 2011. View Article : Google Scholar : PubMed/NCBI
2	Kuttan R, Bhanumathy P, Nirmala K and George MC: Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 29:197–202. 1985. View Article : Google Scholar : PubMed/NCBI
3	Negi PS, Jayaprakasha GK, Jagan Mohan Rao L and Sakariah KK: Antibacterial activity of turmeric oil: A byproduct from curcumin manufacture. J Agric Food Chem. 47:4297–4300. 1999. View Article : Google Scholar : PubMed/NCBI
4	Kunnumakkara AB, Anand P and Aggarwal BB: Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269:199–225. 2008. View Article : Google Scholar : PubMed/NCBI
5	Hasima N and Aggarwal BB: Cancer-linked targets modulated by curcumin. Int J Biochem Mol Biol. 3:328–351. 2012.
6	Kuroyanagi M and Natori S: Some observation on curcuminoids from Zingiberaceae plants. Yakugaku Zasshi. 90:1467–1470. 1970.(In Japanese). PubMed/NCBI
7	Sharma RA, Gescher AJ and Steward WP: Curcumin: The story so far. Eur J Cancer. 41:1955–1968. 2005. View Article : Google Scholar : PubMed/NCBI
8	Kuo ML, Huang TS and Lin JK: Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta. 1317:95–100. 1996. View Article : Google Scholar : PubMed/NCBI
9	Mehta K, Pantazis P, McQueen T and Aggarwal BB: Anti-proliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs. 8:470–481. 1997. View Article : Google Scholar : PubMed/NCBI
10	Chen H, Zhang ZS, Zhang YL and Zhou DY: Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res. 19:3675–3680. 1999.
11	Motterlini R, Foresti R, Bassi R and Green CJ: Curcumin, an anti-oxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic Biol Med. 28:1303–1312. 2000. View Article : Google Scholar : PubMed/NCBI
12	Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res. 67:3853–3861. 2007. View Article : Google Scholar : PubMed/NCBI
13	Chen CC, Chen Y, Hsi YT, Chang CS, Huang LF, Ho CT, Way TD and Kao JY: Chemical constituents and anticancer activity of Curcuma zedoaria roscoe essential oil against non-small cell lung carcinoma cells in vitro and in vivo. J Agric Food Chem. 61:11418–11427. 2013. View Article : Google Scholar : PubMed/NCBI
14	Syu WJ, Shen CC, Don MJ, Ou JC, Lee GH and Sun CM: Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J Nat Prod. 61:1531–1534. 1998. View Article : Google Scholar : PubMed/NCBI
15	Chen X, Pei L, Zhong Z, Guo J, Zhang Q and Wang Y: Anti-tumor potential of ethanol extract of Curcuma phaeocaulis Valeton against breast cancer cells. Phytomedicine. 18:1238–1243. 2011. View Article : Google Scholar : PubMed/NCBI
16	Liu Y, Roy SS, Nebie RHC, Zhang Y and Nair MG: Functional food quality of Curcuma caesia, Curcuma zedoaria and Curcuma aeruginosa endemic to Northeastern India. Plant Foods Hum Nutr. 68:72–77. 2013. View Article : Google Scholar : PubMed/NCBI
17	Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, Kawaguchi M, Hatano E, Kodama Y, Matsumoto S, et al: A phase I study investigating the safety and pharmacokinetics of ^®) in cancer patients. Cancer Chemother Pharmacol. 71:1521–1530. 2013. View Article : Google Scholar : PubMed/NCBI
18	Belcaro G, Hosoi M, Pellegrini L, Appendino G, Ippolito E, Ricci A, Ledda A, Dugall M, Cesarone MR, Maione C, et al: A controlled study of a lecithinized delivery system of curcumin (Meriva^®) to alleviate the adverse effects of cancer treatment. Phytother Res. 28:444–450. 2014. View Article : Google Scholar
19	Lee H and Lin JY: Antimutagenic activity of extracts from anti-cancer drugs in Chinese medicine. Mutat Res. 204:229–234. 1988. View Article : Google Scholar : PubMed/NCBI
20	Peng CH, Chiu WT, Juan CW, Mau JL, Chen CC, Peng CC, Lai EY and Chyau CC: Pivotal role of curcuminoids on the anti-mutagenic activity of Curcuma zedoaria extracts. Drug Chem Toxicol. 33:64–76. 2010. View Article : Google Scholar
21	Kim KI, Kim JW, Hong BS, Shin DH, Cho HY, Kim HK and Yang HC: Antitumor, genotoxicity and anticlastogenic activities of polysaccharide from Curcuma zedoaria. Mol Cells. 10:392–398. 2000.PubMed/NCBI
22	Seo WG, Hwang JC, Kang SK, Jin UH, Suh SJ, Moon SK and Kim CH: Suppressive effect of Zedoariae rhizoma on pulmonary metastasis of B16 melanoma cells. J Ethnopharmacol. 101:249–257. 2005. View Article : Google Scholar : PubMed/NCBI
23	Mau J, Lai EYC, Wang N, Chen C, Chang C and Chyau C: Composition and antioxidant activity of the essential oil from Curcuma zedoaria. Food Chem. 82:583–591. 2003. View Article : Google Scholar
24	Lai EY, Chyau CC, Mau JL, Chen CC, Lai YJ, Shih CF and Lin LL: Antimicrobial activity and cytotoxicity of the essential oil of Curcuma zedoaria. Am J Chin Med. 32:281–290. 2004. View Article : Google Scholar : PubMed/NCBI
25	Wilson B, Abraham G, Manju VS, Mathew M, Vimala B, Sundaresan S and Nambisan B: Antimicrobial activity of Curcuma zedoaria and Curcuma malabarica tubers. J Ethnopharmacol. 99:147–151. 2005. View Article : Google Scholar : PubMed/NCBI
26	Makabe H, Maru N, Kuwabara A, Kamo T and Hirota M: Anti-inflammatory sesquiterpenes from Curcuma zedoaria. Nat Prod Res. 20:680–685. 2006. View Article : Google Scholar : PubMed/NCBI
27	Chen W, Lu Y, Gao M, Wu J, Wang A and Shi R: Anti-angiogenesis effect of essential oil from Curcuma zedoaria in vitro and in vivo. J Ethnopharmacol. 133:220–226. 2011. View Article : Google Scholar
28	Zhou L, Zhang K, Li J, Cui X, Wang A, Huang S, Zheng S, Lu Y and Chen W: Inhibition of vascular endothelial growth factor-mediated angiogenesis involved in reproductive toxicity induced by sesquiterpenoids of Curcuma zedoaria in rats. Reprod Toxicol. 37:62–69. 2013. View Article : Google Scholar : PubMed/NCBI
29	Faried A, Faried LS, Nakagawa T, Yamauchi T, Kitani M, Sasabe H, Nishimura T, Usman N, Kato H, Asao T, et al: Chemically synthesized sugar-cholestanols possess a preferential anticancer activity involving promising therapeutic potential against human esophageal cancer. Cancer Sci. 98:1358–1367. 2007. View Article : Google Scholar : PubMed/NCBI
30	Hashimoto S, Yazawa S, Asao T, Faried A, Nishimura T, Tsuboi K, Nakagawa T, Yamauchi T, Koyama N, Umehara K, et al: Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells. Glycoconj J. 25:531–544. 2008. View Article : Google Scholar
31	Faried A, Arifin MZ, Ishiuchi S, Kuwano H and Yazawa S: Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans. J Neurosurg. 120:1298–1308. 2014. View Article : Google Scholar : PubMed/NCBI
32	Napier KJ, Scheerer M and Misra S: Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities. World J Gastrointest Oncol. 6:112–120. 2014. View Article : Google Scholar : PubMed/NCBI
33	Nishihira T, Hashimoto Y, Katayama M, Mori S and Kuroki T: Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol. 119:441–449. 1993. View Article : Google Scholar : PubMed/NCBI
34	Stoner GD, Kaighn ME, Reddel RR, Resau JH, Bowman D, Naito Z, Matsukura N, You M, Galati AJ and Harris CC: Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res. 51:365–371. 1991.PubMed/NCBI
35	Franken NAP, Rodermond HM, Stap J, Haveman J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc. 1:2315–2319. 2006. View Article : Google Scholar
36	Pretlow TG, Delmoro CM, Dilley GG, Spadafora CG and Pretlow TP: Transplantation of human prostatic carcinoma into nude mice in Matrigel. Cancer Res. 51:3814–3817. 1991.PubMed/NCBI
37	Gorelik B, Ziv I, Shohat R, Wick M, Hankins WD, Sidransky D and Agur Z: Efficacy of weekly docetaxel and bevacizumab in mesenchymal chondrosarcoma: A new theranostic method combining xenografted biopsies with a mathematical model. Cancer Res. 68:9033–9040. 2008. View Article : Google Scholar : PubMed/NCBI
38	Mach CM, Mathew L, Mosley SA, Kurzrock R and Smith JA: Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model. Anticancer Res. 29:1895–1899. 2009.PubMed/NCBI
39	Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X and Lee KC: Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int J Pharm. 403:285–291. 2011. View Article : Google Scholar
40	Gupta SK, Banerjee AB and Achari B: Isolation of Ethyl p-methoxycinnamate, the major antifungal principle of Curcuma zedoaria. Lloydia. 39:218–222. 1976.PubMed/NCBI
41	Carvalho FR, Vassao RC, Nicoletti MA and Maria DA: Effect of Curcuma zedoaria crude extract against tumor progression and immunomodulation. J Venom Anim Toxins Incl Trop Dis. 16:324–341. 2010. View Article : Google Scholar
42	Shin Y and Lee Y: Cytotoxic activity from Curcuma zedoaria through mitochondrial activation on ovarian cancer cells. Toxicol Res. 29:257–261. 2013. View Article : Google Scholar
43	Syed Abdul Rahman SN, Abdul Wahab N and Abd Malek SN: In vitro morphological assessment of apoptosis induced by anti-proliferative constituents from the rhizomes of Curcuma zedoaria. Evid Based Complement Alternat Med. 2013:2571082013. View Article : Google Scholar
44	Fraser M, Leung B, Jahani-Asl A, Yan X, Thompson WE and Tsang BK: Chemoresistance in human ovarian cancer: The role of apoptotic regulators. Reprod Biol Endocrinol. 1:662003. View Article : Google Scholar : PubMed/NCBI
45	Blanco-Aparicio C, Renner O, Leal JF and Carnero A: PTEN, more than the AKT pathway. Carcinogenesis. 28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
46	Georgescu MM: PTEN tumor suppressor network in PI3K-Akt pathway control. Genes Cancer. 1:1170–1177. 2010. View Article : Google Scholar
47	Johnson SM, Gulhati P, Arrieta I, Wang X, Uchida T, Gao T and Evers BM: Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res. 29:3185–3190. 2009.PubMed/NCBI
48	Weng L, Brown J and Eng C: PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways. Hum Mol Genet. 10:237–242. 2001. View Article : Google Scholar : PubMed/NCBI
49	Yu S, Shen G, Khor TO, Kim JH and Kong AN: Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism. Mol Cancer Ther. 7:2609–2620. 2008. View Article : Google Scholar : PubMed/NCBI
50	Torres J, Rodriguez J, Myers MP, Valiente M, Graves JD, Tonks NK and Pulido R: Phosphorylation-regulated cleavage of the tumor suppressor PTEN by caspase-3: Implications for the control of protein stability and PTEN-protein interactions. J Biol Chem. 278:30652–30660. 2003. View Article : Google Scholar : PubMed/NCBI
51	Bharti AC, Donato N and Aggarwal BB: Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol. 171:3863–3871. 2003. View Article : Google Scholar : PubMed/NCBI
52	Liang G, Liu Z, Wu J, Cai Y and Li X: Anticancer molecules targeting fibroblast growth factor receptors. Trends Pharmacol Sci. 33:531–541. 2012. View Article : Google Scholar : PubMed/NCBI
53	Katoh M and Nakagama H: FGF receptors: Cancer biology and therapeutics. Med Res Rev. 34:280–300. 2014. View Article : Google Scholar
54	Hu Y, Lu H and Zhang J, Chen J, Chai Z and Zhang J: Essential role of AKT in tumor cells addicted to FGFR. Anticancer Drugs. 25:183–188. 2014. View Article : Google Scholar
55	Jubb AM, Oates AJ, Holden S and Koeppen H: Predicting benefit from anti-angiogenic agents in malignancy. Nat Rev Cancer. 6:626–635. 2006. View Article : Google Scholar : PubMed/NCBI
56	Li A, Varney ML, Valasek J, Godfrey M, Dave BJ and Singh RK: Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis. 8:63–71. 2005. View Article : Google Scholar : PubMed/NCBI
57	Peng JM, Chen YH, Hung SW, Chiu CF, Ho MY, Lee YJ, Lai TC, Hsiao M, Liang CM and Liang SM: Recombinant viral protein promotes apoptosis and suppresses invasion of ovarian adeno-carcinoma cells by targeting α5β1 integrin to down-regulate Akt and MMP-2. Br J Pharmacol. 165:479–493. 2012. View Article : Google Scholar :